Top Healthcare Stocks
Healthcare stocks were ending lower Wednesday, with the NYSE
Healthcare Sector Index sliding about 0.5% and shares of healthcare
companies in the S&P 500 falling 0.6% as a group.
In company news, shares of Eli Lilly and Co. (
) were up 5% in recent trade after the drug-maker today said its
ramucirumab drug candidate significantly improved cancer patient
survival rates compared to a placebo in late-stage testing.
The trial compared ramucirumab and another commonly used
chemotherapy drug, docetaxel, with a combination of docetaxel with
a placebo, in patients with non-small cell lung cancer.
The trial also showed that the drug combination kept cancers
Shares were up 4.9% at $57.97 each, earlier climbing as high as
$58.18 a share - or just 0.3% under its best price since September
In other sector news,
(+) CHTP, FDA grants accelerated approval of its Northera
(droxidopa) drug treatment for symptomatic neurogenicorthostatic
hypotension. The drug will carry a warning about the risk of
increased blood pressure while lying down.
(-) NPSP, Jefferies cuts investment rating to Hold from Buy with
a $38 price target. Downgrade follows biotech firm reversing
year-ago net loss, posting EPS of $0.07, also topping Street view
by $0.05 per share. Revenue doubles from year-ago period to $54.5
mln, topping estimates by $9.43 mln.
Copyright (C) 2013 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.